Ausgabe Sonderheft 1/2012
Special focus: Biosimilars
Inhalt (9 Artikel)
Biosimilar rhG-CSFs: how similar are they?
Patricia Gravel, Aarti Naik, Jean-Yves Le Cotonnec
Colony stimulating factors (CSF) biosimilars. Progress?
Florian Scotté, Vincent Launay-Vacher, Jean-Baptiste Rey
Risk management of biosimilars in oncology: each medicine is a work in progress
Arnold G. Vulto, Stacy A. Crow
The economic pressures for biosimilar drug use in cancer medicine
Paul Cornes